A statistical comparison of different BSP tests was carried out in normal subjects and in patients with various degrees of chronic liver damage. Only the logarithm of the BSP retention correlated linearly with the physiologically more meaningful determination of the maximal excretory capacity of the liver (BSP Tm, Wheele's method). A double logarithmic transformation was required to correlate the second exponential component of the BSP plasma disappearance curve (k2) with the BSP Tm. When the limitations of these methods are kept in mind, the observed statistical relationships can be used to express hepatic functional deterioration in more physiological terms.
In patients with pulmonary or renal disease it is an established procedure to use quantitative function tests to follow the progression of the disease and/or to assess the effects of various forms of treatment. By contrast, analogous approaches to studying patients with liver diseases have been used only rarely. The need to develop quantitative tests of hepatic function has not been pressing because specific and effective therapy has not been available. Recently, however, clinical trials have accumulated evidence to suggest that chronic active liver disease may be successfully treated with corticosteroid hormones (1) (2) (3) . Consequently quantiative clinical tests to measure partial hepatic functions have become more desirable.
With the presently available sulfobromophthalein-or BSP-tests-as in many other areas of medicine-there is an inverse relationship between simplicity of the procedures and specificity of the information they can give (Table 1) . Indeed, only the measurement of the hepatic transport maximum for BSP can truly be considered to represent a quantitative expression of hepatic excretory function (4) . In practice, the test based on Wheeler's method is cumbersome and time-consuming and, therefore, seems ill-suited for the clinical routine. By contrast, the coventional BSP retention test is widely used and generally accepted. It is technically simple and empirically quite sensitive for the detection of liver disease (5 The third test used to assess liver function is an analysis of the BSP plasma disappearance curve. If frequent samples are taken, the curve may often be described as a double exponential function (6, 7) . Despite the formulation of kinetic models (8), the physiological basis for these curves has remained insufficiently understood.
Consequently, studies in our department were directed to further evaluate the BSP retention and the BSP plasma disappearance curve (5, 9) . In a group of patients with various liver diseases and in normal control subjects, the three tests have been carried out in one session. A comparison of the results revealed that the simple tests may be interpreted in terms of specific partial functions.
The BSP disappearance curves were measured after the intravelnous injection of 5 mg/kg of BSP within 30 sec. Blood samples were obtained at 3, 5, 7, 10, 15, 20, 25, 30, 35, 40, and 45 min after the beginning of the injection. The last sample was used to calculate BSP retention assuming an initial concentration of 10 mg/100 ml.
The BSP Tim was determined indirectly with the two-infusion method as described by Preisig et al. (10) . The principles of this method are based on the idea, that with the chosen experimental conditions, the intravenously infused BSP is either distributed within its volume of distribution-plasma volume (PV) and hepatic storage compartment (S)-or excreted at the rate (Tm) which is maximal for the liver to be studied (4).
The distribution of BSP can be calculated as product of the rate of change in plasma concentration (AC/At) and the volume of distribution (PV + S). Consequently, the equation may be written as: Infusion = Tm + Ac/At (PV + S). As only the rate of infusion and the plasma concentrations can be measured there remain two unknowns (Tm and S). Two different infusions, therefore, have to be administered in order to produce two equations with two unknowns, which then can be solved. The practical application of the test requires consideration of many details which have been discussed elsewhere (4, 11 ) .
The first finding of our comparative analysis consisted of the empirical fact that only the logarithms of the BSP-retention were linearly correlated with the excretory capacity of the liver as revealed by the BSP Tm (Fig. 1 ). This type of relationship implies that the degree of abnormality revealed by the BSP retention has no direct proportionality to the functional deterioration of a diseased liver. The higher the measured BSP retention, the more sensitive it is in revealing changes of excretory function. This observation led to a definition of new BSP retention units. They were constructed to express linearly functional deterioration of the excretory system and can be read directly from the nomogram of Fig. 2 . The normal mean value was regarded as zero retention. The range up to 1.0 retention unit was taken as normal, whereas the higher values correspond to directly proportional decreases in the excretory capacity of the liver for BSP. Application of such retention units to clinical problems should always take into account, however, that they were de- A similar analysis was carried out with the BSP plasma disappearance curve. Its most important finding consisted in the close correlation between the logarithms of the second component (k2) of the disappearance curve (Fig. 3) and the BSP transport maximum, suggesting that k2 is mainly determined by the excretory capacity of the liver (Fig. 4) . In support of this assumption there was no significant relationship between k2 and hepatic blood flow (r = -0.08) as ICG-infusion and extraction technique (12) . Physiologically, ko could be explained on the basis of a two-compartment model, where, in addition, the actual BSP plasma concentrations had to be taken into account. Even though the details, especially the mathematical derivation, are described elsewhere (9) , the model may be regarded as an adequate basis to jutify the use of k2 for estimations of BSP Tm.
In practice, this test requires only four determinations of BSP plasma concentrations, 30, 35, 40, and 45 min after the injection of BSP. The value of k2 is calculated from the graphically read half-life (T1I2) provided three of the four points can be accurately fitted to a straight line (k2 = 0.693/T,1/2). When this condition is not fulfilled, the resulting k2 is inaccurate and should not be used. In our experience, this difficulty occurred in 39% of normal subjects but only in 10% of patients with impaired function. Consequently this procedure is more suitable to assess degrees of abnormality than to define a normal population. The values for k2 obtained with this method, can be converted to "estimated" BSP Tm values with the aid of another nomogram, depicted in Fig. 5 . The specific conditions suggested for the determination of k2 were found by trial and error. The failures to get a straight line between 30 and 45 min after injection of BSP in a high percentage of control subjects were due to the relatively rapid disappearance of BSP from the blood leading to low plasma concentrations which were difficult to measure accurately enough. In patients with impaired liver function, a hump in the curve occasionally rendered k, inaccurate. Severe cholestasis or the Dubin-Johnson syndrome usually were associated with a ko approaching zero. The secondary rise in plasma BSP concentration often seen in these cases generally occurred after 45 min and consequently did not interfere with the assessment of k2.
If further studies on a larger scale confirm the results obtained in our laboratory, the use of BSP k2 and of BSP-retention units should be valuable in the follow-up of patients treated for chronic liver disease. Both tests are simple enough for the clinical routine and give information about quantitative aspects of the excretory function of the liver. Because of its better established physiological basis, the BSP k2 is directly applicable to the individual patient and, therefore, may be preferred. 
